AAAAAA

   
Results: 1-13 |
Results: 13
A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide
Authors: Huitema, ADR Mathot, RAA Tibben, MM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide, J PHARMA PH, 28(3), 2001, pp. 211-230
Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasma
Authors: Huitema, ADR Reinders, C Tibben, MM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasma, J CHROMAT B, 757(2), 2001, pp. 349-357
Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry
Authors: Crul, M van den Bongard, HJGD Tibben, MM van Tellingen, O Sava, G Schellens, JHM Beijnen, JH
Citation: M. Crul et al., Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry, FRESEN J AN, 369(5), 2001, pp. 442-445
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy
Authors: Huitema, ADR Mathot, RAA Tibben, MM Schellens, JHM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy, BR J CL PH, 51(1), 2001, pp. 61-70
Validation of a therapeutic drug monitoring strategy for thiotepa in a high-dose chemotherapy regimen
Authors: Huitema, ADR Mathot, RAA Tibben, MM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Validation of a therapeutic drug monitoring strategy for thiotepa in a high-dose chemotherapy regimen, THER DRUG M, 23(6), 2001, pp. 650-657
Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatography
Authors: Huitema, ADR Tibben, MM Kerbusch, T Kettenes-van den Bosch, JJ Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatography, J CHROMAT B, 745(2), 2000, pp. 345-355
Simultaneous determination of ifosfamide and its metabolite ifosforamide mustard in human plasma by high performance liquid chromatography
Authors: Kerbusch, T Huitema, ADR Jeuken, MJJ Derraz, J Tibben, MM Beijnen, JH
Citation: T. Kerbusch et al., Simultaneous determination of ifosfamide and its metabolite ifosforamide mustard in human plasma by high performance liquid chromatography, J LIQ CHR R, 23(19), 2000, pp. 2991-3010
High performance liquid chromatographic determination of the stabilized cyclophosphamide metabolite 4-hydroxycyclophosphamide in plasma and red bloodcells
Authors: Huitema, ADR Tibben, MM Kerbusch, T Kettenes-van den Bosch, JJ Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., High performance liquid chromatographic determination of the stabilized cyclophosphamide metabolite 4-hydroxycyclophosphamide in plasma and red bloodcells, J LIQ CHR R, 23(11), 2000, pp. 1725-1744
Validated method for the determination of platinum from a liposomal source(SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry
Authors: Terwogt, JMM Tibben, MM Welbank, H Schellens, JHM Beijnen, JH
Citation: Jmm. Terwogt et al., Validated method for the determination of platinum from a liposomal source(SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry, FRESEN J AN, 366(3), 2000, pp. 298-302
Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens
Authors: Huitema, ADR Kerbusch, T Tibben, MM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Reduction of cyclophosphamide bioactivation by thioTEPA: critical sequence-dependency in high-dose chemotherapy regimens, CANC CHEMOT, 46(2), 2000, pp. 119-127
Degradation of azaglycinamido residues in model tripeptides derived from goserelin
Authors: Hoitink, MA Beijnen, JH Bult, A Damen, JMA Van der Houwen, OAGJ Kruijtzer, JAW Tibben, MM Wiese, G Underberg, WJM
Citation: Ma. Hoitink et al., Degradation of azaglycinamido residues in model tripeptides derived from goserelin, J PHARM SCI, 89(1), 2000, pp. 108-114
Validation of techniques for the prediction of carboplatin exposure: Application of Bayesian methods
Authors: Huitema, ADR Mathot, RAA Tibben, MM Schellens, JHM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Validation of techniques for the prediction of carboplatin exposure: Application of Bayesian methods, CLIN PHARM, 67(6), 2000, pp. 621-630
Sampling technique from central venous catheters proves critical for pharmacokinetic studies
Authors: Huitema, ADR Holtkamp, M Tibben, MM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Sampling technique from central venous catheters proves critical for pharmacokinetic studies, THER DRUG M, 21(1), 1999, pp. 102-104
Risultati: 1-13 |